National Vision Holdings, Inc. (NASDAQ:EYE) Given Average Rating of “Moderate Buy” by Analysts

Shares of National Vision Holdings, Inc. (NASDAQ:EYE) have been assigned a consensus recommendation of “Moderate Buy” from the thirteen ratings firms that are presently covering the company, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating, six have given a buy rating and two have given a strong buy rating to the company. The average 12 month target price among brokerages that have updated their coverage on the stock in the last year is $29.00.

Several brokerages recently commented on EYE. National Bank Financial set a $32.00 target price on National Vision in a research report on Tuesday, December 9th. Wall Street Zen lowered National Vision from a “buy” rating to a “hold” rating in a research note on Saturday, November 8th. Zacks Research raised shares of National Vision from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, January 20th. Barclays lifted their price objective on shares of National Vision from $28.00 to $30.00 and gave the company an “overweight” rating in a research note on Tuesday, November 18th. Finally, Morgan Stanley raised their price target on shares of National Vision from $26.00 to $30.00 and gave the stock an “equal weight” rating in a report on Thursday, January 15th.

Institutional Trading of National Vision

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Wellington Management Group LLP boosted its holdings in National Vision by 27.6% in the fourth quarter. Wellington Management Group LLP now owns 5,783,699 shares of the company’s stock worth $149,335,000 after acquiring an additional 1,251,499 shares in the last quarter. William Blair Investment Management LLC raised its position in shares of National Vision by 36.0% during the third quarter. William Blair Investment Management LLC now owns 4,840,473 shares of the company’s stock worth $141,293,000 after purchasing an additional 1,280,783 shares during the period. American Century Companies Inc. lifted its holdings in shares of National Vision by 25.6% in the 3rd quarter. American Century Companies Inc. now owns 4,391,844 shares of the company’s stock worth $128,198,000 after purchasing an additional 896,093 shares in the last quarter. Arrowstreet Capital Limited Partnership lifted its holdings in shares of National Vision by 15.3% in the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 3,295,290 shares of the company’s stock worth $96,190,000 after purchasing an additional 437,655 shares in the last quarter. Finally, Dimensional Fund Advisors LP grew its position in National Vision by 5.5% in the 4th quarter. Dimensional Fund Advisors LP now owns 3,029,596 shares of the company’s stock valued at $78,224,000 after purchasing an additional 156,859 shares during the period.

National Vision Price Performance

Shares of NASDAQ EYE opened at $27.26 on Friday. The company has a market capitalization of $2.16 billion, a PE ratio of -908.36, a P/E/G ratio of 1.47 and a beta of 1.39. The company has a quick ratio of 0.32, a current ratio of 0.53 and a debt-to-equity ratio of 0.28. National Vision has a twelve month low of $10.45 and a twelve month high of $30.02. The firm has a fifty day simple moving average of $27.29 and a 200 day simple moving average of $26.39.

About National Vision

National Vision Holdings, Inc is an American optical retailer specializing in accessible vision care and eyewear. The company operates under multiple retail banners, offering comprehensive eye health services and a wide range of optical products. Since its founding in the early 1990s, National Vision has focused on providing value-driven solutions, targeting underserved and price‐conscious consumer segments.

Through its primary retail brands—including America’s Best Contacts & Eyeglasses, Eyeglass World, Optical America and Vista Optical—National Vision delivers services such as comprehensive eye examinations, prescription eyewear, contact lenses, sunglasses and lens accessories.